OTHERS SOLUTION GROUP BERHAD ("SGB" or "THE COMPANY") APPROVAL OF FACILITY DESIGN PLAN AND LAYOUT BY NATIONAL PHARMACEUTICAL REGULATORY AGENCY, MINISTRY OF HEALTH ("NPRA")
| SOLUTION GROUP BERHAD |
| Type | Announcement |
| Subject | OTHERS |
| Description | SOLUTION GROUP BERHAD ("SGB" or "THE COMPANY")
APPROVAL OF FACILITY DESIGN PLAN AND LAYOUT BY NATIONAL PHARMACEUTICAL REGULATORY AGENCY, MINISTRY OF HEALTH ("NPRA") |
|
Reference is made to the announcement dated 25 November 2020 where it was stated that the Company had on 13 October 2020 submitted the facility design plan and layout of the vaccine fill and finish facility to NPRA for approval.
The Board of Director of SGB wishes to announce that NPRA had vide its letter dated 14 December 2020 (which was received on 17 December 2020) approved the said facility design plan and layout.
The Company will commence the establishment of the fill and finish facility after the receipt of the approval from shareholders of SGB on the proposed diversification of the existing business of SGB and its subsidiaries to include the pharmaceutical related business, at an extraordinary general meeting to be convened.
This announcement is dated 17 December 2020. |
|
Announcement Info
| Company Name | SOLUTION GROUP BERHAD |
| Stock Name | SOLUTN |
| Date Announced | 17 Dec 2020 |
| Category | General Announcement for PLC |
| Reference Number | GA1-17122020-00031 |